Trials Starting With "F"

Factor IX a Inhibition Aptamer Technology Overview and First Results with RB006/RB007

      -Factor IX a Inhibition Aptamer Technology Overview and First Results with RB006/RB007 by Dr. Mauricio G. Cohen (TCT 2009)

FAILS: Failure In Left Main Study

      -Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of 718 patients by Dr. Giuseppe Biondi-Zoccai

FAME: Federal Study of Adherence to Medications

      -Trial Overview by Dr. Allen Taylor (AHA 2006)

FAME: Fractional Flow Reserve versus Angiography for Multivessel Evaluation

      -1 Year Follow-Up by Dr. Nico H. J. Pijls (TCT 2008)

      -2 Year Follow-Up by Dr. William Fearon (TCT 2009)

FAME 2: Fractional Flow Reserve-Guided PCI Versus Medical Therapy in Stable Coronary Artery Disease

      -Trial Overview by Dr. Bernard De Bruyne (ESC 2012)

      -A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease by Dr. William F. Fearon (TCT 2012)

FAST: Femoral Artery Stenting Trial

      -FAST (Femoral Artery Stenting Trial) Final Results by Dr. Hans Krankenberg

 

FAST: Atrial Fibrillation Catheter Ablation vs. Surgical Ablation Treatment: A Multicenter Randomized Clinical Trial

      -Trial Overview by Dr. Lucas Boersma (AHA 2011)

 

FASTER: Fibrinolytic And Aggrastat ST Elevation Resolution Trial

      -FASTER Trial Results

FATA: Facilitated Angioplasty with Tirofiban or Abciximab

      -FATA Trial: Facilitated Angioplasty with Tirofiban or Abciximab by Dr. Francesco Saia (TCT 2008)

FAUST: The Femoral Arterial Access with Ultrasound Trial

      -Trial Overview by Dr. Arnold Seto (TCT 2009)

FIELD: Fenofibrate Intervention and Event Lowering in Diabetes

      -Fenofibrate Intervention and Event Lowering in Diabetes by Dr. Anthony Keech (AHA 2005)

FilterWire-Ex in Primary PCI

      -Mechanical Prevention of Distal Embolization During Primary Angioplasty: Safety, Feasibility, and Impact on Myocardial Reperfusion by Dr. Ugo Limbruno

FINESSE: Facilitated Intervention With Enhanced Reperfusion Speed To Stop Events

      -FINESSE Study Design and Results presented at ESC 2007

      -Enoxaparin in primary PCI From FINESSE to ATOLL by Dr. G. Montalescot (TCT 2008)

FIRE: A Multicenter, Double-blind, Randomized, Placebo-Controlled Study to Measure the Effect of FX06 (a fibrin-derived peptide Bβ15-42) on Ischemia-REperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention

      -FIRE Study: A Multicenter, Double-blind, Randomized, Placebo-Controlled Study to Measure the Effect of FX06 (a fibrin-derived peptide Bβ15-42) on Ischemia-REperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention by Dr. Dan Atar (ESC 2008)

 

F1RST: Correlation Between Radiofrequency Intravascular Ultrasound and Fractional Flow Reserve Parameters in Patients with Intermediate Coronary Stenoses

      -Trial Overview by Dr. Ron Waksman (TCT 2011)

FIT HEART: A Novel Family-based Interventional Trial to Improve Heart Health

      -A Novel Family-based Interventional Trial to Improve Heart Health (FIT HEART): Results of a Randomized Controlled Trial by Dr. Lori Mosca

 

FOCUS: Effect of Transendocardial Autologous Bone Marrow Mononuclear Cell Delivery on Functional Capacity, Left Ventricular Function and Perfusion in Chronic Ischemic Heart Failure

      -Trial Overview by Dr. Emerson C. Perin (ACC 2012)

Fondaparinux: A Synthetic Factor Xa Inhibitor

      -Fondaparinux: A Synthetic Factor Xa Inhibitor

 

Frail Older Adults at Risk for Loss of Independence Following MI:

      -Poster by Dr. Karen Alexander (AHA 2010)

FREEDOM: Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease

      -Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease by Dr. Michael Farkouh (TCT 2008)

      -Main Results by Dr. Valentin Fuster (AHA 2012)

      -Cost-Effectiveness of PCI with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multi-vessel Coronary Artery Disease by Dr. Elizabeth A. Magnuson (AHA 2012)

FRISC II: Framing and Fast Revascularization during Instability in Coronary Artery Disease

      -Framing and Fast Revascularization during Instability in Coronary Artery Disease (FRISC II): Five-Year Follow-up of the FRISC-II Invasive Study by Dr. Bo Lagerqvist (ESC 2006)

FUSION II: Follow-Up Serial Infusions of Nesiritide for the Management of Patients With Heart Failure

      -Resultados del Seguimiento de infusiones seriales de Nesiritide para el manejo de pacientes con Falla Cardiaca [Avanzada] por el Dr. Clyde W. Yancy (ACC 2007) Spanish

      -FUSION II: Follow-Up Serial Infusions of Nesiritide for the Management of Patients with Heart Failure by Dr. Clyde W. Yancy (ACC 2007)

 

FUTURA OASIS 8: Low vs. Standard Dose Unfractionated Heparin for PCI in ACS Patients Treated with Fondaparinux

      -Trial Results by Dr. Sanjit Jolly (ESC 2010)

 

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs test

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster